BioNxt Solutions (BXT) Ratios
BioNxt Solutions Ratios
DE:BXT's free cash flow for Q2 2026 was $-843.31K. For the 2026 fiscal year, DE:BXT's free cash flow was increased by $0.00 and operating cash flow was $-843.31K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.05 | 0.02 | 0.11 | 0.34 | 0.50 |
| Quick Ratio | 0.05 | 0.02 | 0.11 | 0.34 | 0.36 |
| Cash Ratio | 0.01 | 0.00 | 0.06 | 0.07 | 0.25 |
| Solvency Ratio | -0.70 | -0.62 | -1.15 | -2.12 | -2.46 |
| Operating Cash Flow Ratio | -0.87 | -0.44 | -0.79 | -3.09 | -2.23 |
| Short-Term Operating Cash Flow Coverage | -2.64 | -1.11 | -1.06 | -10.17 | -4.08 |
| Net Current Asset Value | $ -9.63M | $ -8.27M | $ -5.83M | $ -5.05M | $ -5.35M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 10.05 | 7.52 | 3.86 | 2.71 | 0.56 |
| Debt-to-Equity Ratio | -0.63 | -0.54 | -0.93 | -1.06 | 3.27 |
| Debt-to-Capital Ratio | -1.74 | -1.19 | -12.60 | 18.02 | 0.77 |
| Long-Term Debt-to-Capital Ratio | -0.74 | -0.25 | 0.00 | -9.20 | 0.50 |
| Financial Leverage Ratio | -0.06 | -0.07 | -0.24 | -0.39 | 5.83 |
| Debt Service Coverage Ratio | -1.72 | -1.14 | -1.09 | -6.28 | -5.15 |
| Interest Coverage Ratio | -4.20 | -4.52 | -6.11 | -5.29 | -22.29 |
| Debt to Market Cap | 0.08 | 0.10 | 0.10 | 0.09 | 0.06 |
| Interest Debt Per Share | 0.06 | 0.05 | 0.06 | 0.07 | 0.09 |
| Net Debt to EBITDA | -0.98 | -0.98 | -0.70 | -0.37 | -0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 65.77% | 69.63% |
| EBIT Margin | 0.00% | -16365.19% | -1794.61% | -3942.76% | -6986.43% |
| EBITDA Margin | 0.00% | -16025.15% | -1742.02% | -3870.28% | -6699.09% |
| Operating Profit Margin | 0.00% | -16487.95% | -1710.51% | -2032.30% | -5692.90% |
| Pretax Profit Margin | 0.00% | -20015.92% | -2074.68% | -4326.89% | -7241.88% |
| Net Profit Margin | 0.00% | -19683.18% | -2074.68% | -4160.84% | -7203.23% |
| Continuous Operations Profit Margin | 0.00% | -19683.18% | -2074.68% | -4160.84% | -7203.23% |
| Net Income Per EBT | 97.27% | 98.34% | 100.00% | 96.16% | 99.47% |
| EBT Per EBIT | 119.35% | 121.40% | 121.29% | 212.91% | 127.21% |
| Return on Assets (ROA) | -1187.37% | -932.90% | -609.28% | -767.47% | -212.17% |
| Return on Equity (ROE) | 75.01% | 67.56% | 146.19% | 299.78% | -1236.76% |
| Return on Capital Employed (ROCE) | 112.42% | 70.53% | 120.53% | 1493.49% | -381.34% |
| Return on Invested Capital (ROIC) | 172.18% | 122.16% | 1638.92% | -2395.95% | -219.04% |
| Return on Tangible Assets | -1187.37% | -932.90% | -609.28% | -767.47% | -538.40% |
| Earnings Yield | -9.29% | -12.55% | -15.38% | -25.04% | -27.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.45 | 1.32 | 0.65 | 0.52 |
| Payables Turnover | 0.02 | 0.08 | 0.00 | 0.22 | 0.17 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Fixed Asset Turnover | 0.00 | 0.07 | 0.68 | 0.32 | 0.25 |
| Asset Turnover | 0.00 | 0.05 | 0.29 | 0.18 | 0.03 |
| Working Capital Turnover Ratio | 0.00 | -0.00 | -0.10 | -0.15 | -0.48 |
| Cash Conversion Cycle | -23842.87 | -3606.80 | 277.06 | -1089.70 | 1583.01 |
| Days of Sales Outstanding | 0.00 | 819.66 | 277.06 | 562.91 | 696.02 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 3087.79 |
| Days of Payables Outstanding | 23842.87 | 4426.46 | 0.00 | 1652.60 | 2200.80 |
| Operating Cycle | 0.00 | 819.66 | 277.06 | 562.91 | 3783.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.04 | -0.03 | -0.05 | -0.07 | -0.17 |
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.06 | -0.07 | -0.18 |
| Dividend Paid and CapEx Coverage Ratio | -1298958.50 | 0.00 | -25.66 | -1614.75 | -26.87 |
| Capital Expenditure Coverage Ratio | -1298958.50 | 0.00 | -25.66 | -1614.75 | -26.87 |
| Operating Cash Flow Coverage Ratio | -0.87 | -0.71 | -1.06 | -1.43 | -2.23 |
| Operating Cash Flow to Sales Ratio | 0.00 | -112.44 | -13.88 | -20.94 | -42.43 |
| Free Cash Flow Yield | -6.87% | -7.17% | -10.70% | -12.61% | -16.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.76 | -7.97 | -6.50 | -3.99 | -3.68 |
| Price-to-Sales (P/S) Ratio | 0.00 | 1568.84 | 134.85 | 166.17 | 264.76 |
| Price-to-Book (P/B) Ratio | -8.07 | -5.39 | -9.50 | -11.97 | 45.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.55 | -13.95 | -9.35 | -7.93 | -6.02 |
| Price-to-Operating Cash Flow Ratio | -14.55 | -13.95 | -9.71 | -7.93 | -6.24 |
| Price-to-Earnings Growth (PEG) Ratio | -0.43 | 0.20 | 0.14 | 0.08 | 1.10 |
| Enterprise Value Multiple | -13.49 | -10.77 | -8.44 | -4.66 | -4.17 |
| Enterprise Value | 81.50M | 46.58M | 54.73M | 53.66M | 79.96M |
| EV to EBITDA | -13.49 | -10.77 | -8.44 | -4.66 | -4.17 |
| EV to Sales | 0.00 | 1726.24 | 147.02 | 180.41 | 279.09 |
| EV to Free Cash Flow | -15.69 | -15.35 | -10.19 | -8.61 | -6.34 |
| EV to Operating Cash Flow | -15.69 | -15.35 | -10.59 | -8.61 | -6.58 |
| Tangible Book Value Per Share | -0.08 | -0.07 | -0.05 | -0.05 | -0.06 |
| Shareholders’ Equity Per Share | -0.08 | -0.07 | -0.05 | -0.05 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.02 | 0.00 | 0.04 | 0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.06 | -0.05 | -0.08 | -0.15 | -0.29 |
| Tax Burden | 0.97 | 0.98 | 1.00 | 0.96 | 0.99 |
| Interest Burden | 1.19 | 1.22 | 1.16 | 1.10 | 1.04 |
| Research & Development to Revenue | 0.00 | 53.02 | 6.86 | 7.10 | 11.67 |
| SG&A to Revenue | 0.00 | 103.64 | 7.44 | 10.94 | 23.92 |
| Stock-Based Compensation to Revenue | 0.00 | 20.23 | 1.65 | 0.38 | 11.43 |
| Income Quality | 0.74 | 0.57 | 0.67 | 0.50 | 0.59 |
Currency in CAD
